Not currently recruiting at University of California Health
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD
- Dates
- study startedcompletion around
- Principal Investigator
- by Peter Vu, MD (ucsd)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Peter Vu, MD (ucsd)
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Immuneering Corporation
- ID
- NCT05585320
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 210 study participants
- Last Updated